Eledon Pharmaceuticals logo

Eledon Pharmaceuticals Share Price (NASDAQ: ELDN)

$2.6

0.03

(1.17%)

Last updated on

Check the interactive Eledon Pharmaceuticals Stock chart to analyse performance

Eledon Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.55
    Today's High:$2.64

    Day's Volatility :3.42%

  • 52 Weeks Low:$2.38
    52 Weeks High:$5.54

    52 Weeks Volatility :57.13%

Eledon Pharmaceuticals Stock Returns

PeriodEledon Pharmaceuticals IncIndex (Russel 2000)
3 Months
-15.36%
0.0%
6 Months
-35.33%
0.0%
1 Year
-5.47%
0.0%
3 Years
-27.86%
-4.7%

Eledon Pharmaceuticals Inc Key Stats

Check Eledon Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.57
Open
$2.59
Today's High
$2.635
Today's Low
$2.545
Market Capitalization
$153.9M
Today's Volume
$490.7K
52 Week High
$5.54
52 Week Low
$2.375
Revenue TTM
$0.0
EBITDA
$-36.9M
Earnings Per Share (EPS)
$0.65
PE Ratio
3.95
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
30.03%

Stock Returns calculator for Eledon Pharmaceuticals Stock including INR - Dollar returns

The Eledon Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Eledon Pharmaceuticals investment value today

Current value as on today

₹1,00,175

Returns

₹175

(+0.17%)

Returns from Eledon Pharmaceuticals Stock

₹5,109 (-5.11%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Eledon Pharmaceuticals Stock

-23%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Eledon Pharmaceuticals Stock from India on INDmoney has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Eledon Pharmaceuticals Inc

  • Name

    Holdings %

  • Bvf Inc

    10.51%

  • RA Capital Management, LLC

    5.96%

  • Vanguard Group Inc

    5.54%

  • First Light Asset Management, LLC

    4.34%

  • Sphera Funds Management Ltd.

    3.27%

  • Woodline Partners LP

    2.79%

Analyst Recommendation on Eledon Pharmaceuticals Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Eledon Pharmaceuticals(by analysts ranked 0 to 5 stars)

Eledon Pharmaceuticals Share Price Target

What analysts predicted

Upside of 265.38%

Target:

$9.50

Current:

$2.60

Eledon Pharmaceuticals share price target is $9.50, a slight Upside of 265.38% compared to current price of $2.60 as per analysts' prediction.

Eledon Pharmaceuticals Stock Insights

  • Price Movement

    In the last 1 month, ELDN stock has moved down by -18.0%
  • ELDN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 77.7%
  • ELDN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 145.8%

Eledon Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Eledon Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Eledon Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Eledon Pharmaceuticals Inc logo
-17.78%
-35.33%
-5.47%
-27.86%
-82.85%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Eledon Pharmaceuticals Inc

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Organization
Eledon Pharmaceuticals
Employees
31
CEO
Dr. David-Alexandre C. Gros M.D., Ph.D.
Industry
Miscellaneous

Key Management of Eledon Pharmaceuticals Inc

NameTitle
Dr. David-Alexandre C. Gros M.D., Ph.D.
CEO & Non Independent Director
Dr. Steven N. Perrin Ph.D.
President, Chief Scientific Officer & Non Independent Director
Mr. Paul Sean Little
Chief Financial Officer
Mr. John Herberger
Vice President of Technical Operations
Mr. Bryan E. Smith J.D.
General Counsel, Corporate Secretary & Chief Compliance Officer
Dr. David Hovland Ph.D.
Chief Regulatory Officer
Dr. Eliezer Katz F.A.C.S., FACS, M.D.
Chief Medical Officer
Ms. Marina Escudero
VP & Head of Clinical Operations

Important FAQs about investing in ELDN Stock from India :

What is Eledon Pharmaceuticals share price today?

Eledon Pharmaceuticals share price today is $2.60 as on at the close of the market. Eledon Pharmaceuticals share today touched a day high of $2.64 and a low of $2.55.

What is the 52 week high and 52 week low for Eledon Pharmaceuticals share?

Eledon Pharmaceuticals share touched a 52 week high of $5.54 and a 52 week low of $2.38. Eledon Pharmaceuticals stock price today i.e. is closed at $2.60, lower by 53.07% versus the 52 week high.

How to invest in Eledon Pharmaceuticals Stock (ELDN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Eledon Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eledon Pharmaceuticals Shares that will get you 0.5769 shares as per Eledon Pharmaceuticals share price of $2.60 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Eledon Pharmaceuticals Stock (ELDN) from India?

Indian investors can start investing in Eledon Pharmaceuticals (ELDN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Eledon Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Eledon Pharmaceuticals share’s latest price of $2.60 as on August 30, 2025 at 1:29 am IST, you will get 3.8462 shares of Eledon Pharmaceuticals. Learn more about fractional shares .

What are the returns that Eledon Pharmaceuticals has given to Indian investors in the last 5 years?

Eledon Pharmaceuticals stock has given -82.85% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?